STOCK TITAN

[SCHEDULE 13D/A] Ainos, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Ainos Inc. amended its Schedule 13D to report ownership and recent transactions involving the issuer's common stock. After a June 30, 2025 one-for-five reverse stock split, Ainos KY directly holds 491,263 shares, representing 9.13% of the expanded share count basis. The filing discloses additional voting relationships: 933,958 shares under a January 26, 2024 voting agreement with the Tsai Group, 100,500 shares under a March 7, 2024 voting agreement, 635,652 shares tied to ASE Test via a May 3, 2024 agreement (including convertible notes and warrants), 1,037,206 shares under an August 15, 2024 agreement with TCNT, and 55,275 shares under a March 10, 2025 agreement.

The filing states the direct holdings of 491,263 shares were acquired for investment purposes, while TCNT sold 62,794 shares between June 25, 2025 and October 6, 2025 for general operating purposes. No other material contracts beyond the disclosed voting agreements are reported.

Ainos Inc. ha aggiornato il proprio Schedule 13D per riferire proprietà e transazioni recenti relative all'azioni ordinarie dell'emittente. Dopo uno split azionario inverso di 30 giugno 2025 di una a cinque, Ainos KY possiede direttamente 491,263 azioni, che rappresentano 9,13% del numero di azioni post-split ampliato. La dichiarazione rende note ulteriori relazioni di voto: 933,958 azioni in virtù di un accordo di voto datato 26 gennaio 2024100,500 azioni in base a un accordo di voto datato 7 marzo 2024, 635,652 azioni legate a ASE Test tramite un accordo datato 3 maggio 2024 (inclusi convertibili e warrant), 1,037,206 azioni in base a un accordo datato 15 agosto 202455,275 azioni in base a un accordo datato 10 marzo 2025.

La dichiarazione indica che le detenzioni dirette di 491,263 azioni sono state acquisite per scopi di investimento, mentre TCNT ha venduto 62,794 azioni tra 25 giugno 2025 e 6 ottobre 2025 per scopi operativi generali. Nessun altro contratto materiale oltre agli accordi di voto divulgati è riportato.

Ainos Inc. modificó su Schedule 13D para reportar la propiedad y las transacciones recientes relacionadas con las acciones ordinarias del emisor. Después de un split inverso 1 por 5 de acciones el 30 de junio de 2025, Ainos KY posee directamente 491,263 acciones, que representan 9.13% de la base ampliada de recuento de acciones. El informe revela relaciones de voto adicionales: 933,958 acciones bajo un acuerdo de voto del 26 de enero de 2024 con el Tsai Group, 100,500 acciones bajo un acuerdo de voto del 7 de marzo de 2024, 635,652 acciones vinculadas a ASE Test mediante un acuerdo del 3 de mayo de 2024 (incluidos los notas convertibles y warrants), 1,037,206 acciones bajo un acuerdo del 15 de agosto de 2024 con TCNT, y 55,275 acciones bajo un acuerdo del 10 de marzo de 2025.

La declaración indica que las participaciones directas de 491,263 acciones se obtuvieron para propósitos de inversión, mientras que TCNT vendió 62,794 acciones entre 25 de junio de 2025 y 6 de octubre de 2025 para fines operativos generales. No se reportan otros contratos materiales además de los acuerdos de voto divulgados.

Ainos Inc. 의 Schedule 13D 를 개정하여 발행인의 보통주에 대한 소유 및 최근 거래를 보고합니다. 2025년 6월 30일의 1대5 역분할 이후, Ainos KY 가 직접 보유한 주식은 491,263 주로 확장된 주식수 기준의 9.13% 를 차지합니다. 공시는 추가적인 의결 관계를 밝힙니다: 933,958 주는 2024년 1월 26일 Tsai Group과의 의결계약, 100,500 주는 2024년 3월 7일 의결계약, 635,652 주는 2024년 5월 3일 ASE Test 와의 계약(전환사채 및 워런트 포함), 1,037,206 주는 2024년 8월 15일 TCNT 와의 계약, 55,275 주는 2025년 3월 10일 계약에 따라 입니다.

해당 491,263 주의 직접 보유분은 투자 목적 으로 취득되었으며, TCNT 는 2025년 6월 25일에서 2025년 10월 6일 사이에 62,794 주를 매도하여 일반 운용 목적을 달성했습니다. 공시된 의결계약 외의 다른 중요한 계약은 보고되지 않습니다.

Ainos Inc. a modifié son Schedule 13D pour rendre compte de la propriété et des transactions récentes concernant les actions ordinaires de l'émetteur. Après une scission inverse de 30 juin 2025 d'un pour cinq, Ainos KY détient directement 491,263 actions, ce qui représente 9,13% du nombre d'actions post-split élargi. Le dossier révèle des relations de vote supplémentaires : 933,958 actions dans le cadre d'un accord de vote daté du 26 janvier 2024 avec le Tsai Group, 100,500 actions dans le cadre d'un accord de vote daté du 7 mars 2024, 635,652 actions liées à ASE Test via un accord daté du 3 mai 2024 (y compris les notes convertibles et les warrants), 1,037,206 actions dans le cadre d'un accord daté du 15 août 2024 avec TCNT, et 55,275 actions dans le cadre d'un accord daté du 10 mars 2025.

Le dossier indique que les détentions directes de 491,263 actions ont été acquises à des fins d'investissement, tandis que TCNT a vendu 62,794 actions entre le 25 juin 2025 et le 6 octobre 2025 pour des fins d'exploitation générale. Aucun autre contrat matériel au-delà des accords de vote divulgués n'est signalé.

Ainos Inc. hat seinen Schedule 13D geändert, um Eigentum und jüngste Transaktionen im Zusammenhang mit den Stammaktien des Emittenten zu melden. Nach einem 6/30/2025 1-für-5-Reverse-Split hält Ainos KY direkt 491,263 Aktien, was 9,13% der erweiterten Aktienanzahl entspricht. Die Einreichung offenbart zusätzliche Stimmrechtsverhältnisse: 933,958 Aktien gemäß einer Abstimmungsvereinbarung vom 26.01.2024 mit der Tsai-Gruppe, 100,500 Aktien gemäß einer Abstimmungsvereinbarung vom 07.03.2024, 635,652 Aktien im Zusammenhang mit ASE Test durch eine Vereinbarung vom 03.05.2024 (einschließlich Wandelanleihen und Warrants), 1,037,206 Aktien gemäß einer Vereinbarung vom 15.08.2024 mit TCNT und 55,275 Aktien gemäß einer Vereinbarung vom 10.03.2025.

Die Einreichung gibt an, dass die direkten Halte von 491,263 Aktien zu Anlagedispositionszwecken erworben wurden, während TCNT zwischen dem 25.06.2025 und dem 06.10.2025 62,794 Aktien verkauft hat, für allgemeine Betriebsausgaben. Es werden keine weiteren materiellen Verträge außer den offengelegten Abstimmungsvereinbarungen berichtet.

Ainos Inc. عدلت جدولها 13D للإبلاغ عن الملكية والمعاملات الأخيرة المتعلقة بأسهم الشركة العادية. بعد تقسيم عكسي واحد من خمسة للأسهم في 30 يونيو 2025، تمتلك Ainos KY بشكل مباشر 491,263 سهمًا، وتمثل 9.13% من إجمالي الأسهم الموسعة. تكشف الشهادة عن علاقات تصويت إضافية: 933,958 سهمًا بموجب اتفاقية تصويت بتاريخ 26 يناير 2024 مع Tsai Group، 100,500 سهمًا بموجب اتفاقية تصويت بتاريخ 7 مارس 2024، 635,652 سهمًا مرتبطة بـ ASE Test عبر اتفاقية في 3 مايو 2024 (بما في ذلك السندات القابلة للتحويل والمذكرات)، 1,037,206 سهمًا بموجب اتفاقية في 15 أغسطس 2024 مع TCNT، و 55,275 سهمًا بموجب اتفاقية في 10 مارس 2025.

وتذكر الشهادة أن الحيازات المباشرة لـ 491,263 سهمًا قد اكتُسبت لغرض الاستثمار، بينما باع TCNT 62,794 سهمًا بين 25 يونيو 2025 و 6 أكتوبر 2025 لأغراض تشغيلية عامة. لا يُذكر أي عقود مادية أخرى بخلاف اتفاقيات التصويت المعلنة.

Ainos Inc. 修改了其 Schedule 13D,以报告发行人普通股的所有权和近期交易。在 2025年6月30日 的五对一反向拆股之后,Ainos KY 直接持有 491,263 股,基于扩大的股本基数占 9.13%。 filing 还披露了额外的表决关系:933,958 股根据2024年1月26日与 Tsai Group 的表决协议,100,500 股根据2024年3月7日的表决协议,635,652 股通过与 ASE Test 的2024年5月3日 的协议相关(包括可转换票据和权证),1,037,206 股根据2024年8月15日与 TCNT 的协议,和 55,275 股根据2025年3月10日的协议。

声明称,491,263 股的直接持有是出于 投资目的 而取得,而 TCNT 在2025年6月25日2025年10月6日之间出售了 62,794 股,用于一般运营目的。除所披露的表决协议外,未报告其他重大合同。

Positive
  • Direct stake of 491,263 shares provides clear disclosed economic interest
  • Voting agreements cover large blocks (totaling over 2.8M shares) which can coordinate votes
Negative
  • Direct economic ownership is limited to 9.13% despite broader voting arrangements
  • ASE Test's position includes convertible securities and warrants that may dilute or change control if exercised

Insights

Voting agreements concentrate influence while direct economic ownership is modest.

The reporting party, Ainos KY, holds 491,263 shares directly (9.13% basis) and controls additional voting blocks through multiple voting agreements totaling over 2.8M shares combined, which amplifies its practical voting influence beyond its direct economic stake.

This structure depends on the continued enforceability and terms of the voting agreements and on no material dilution beyond the shares already disclosed. Watch near-term filings for any amendments to these agreements or further sales between now and Q4 2025 that could change voting control or economic exposure.

Recent sales by TCNT modestly reduce affiliated economic exposure but leave voting control mechanisms intact.

TCNT sold 62,794 shares from June 25, 2025 to October 6, 2025 for operating needs; the Schedule clarifies those shares remain subject to the TCNT Voting Agreement for voting purposes where applicable.

Investors should monitor subsequent Schedule 13 filings for changes in percent ownership, disclosures about convertible note conversions or warrant exercises tied to ASE Test, and any new statements revising the issuer's outstanding share count or voting arrangements over the next few quarters.

Ainos Inc. ha aggiornato il proprio Schedule 13D per riferire proprietà e transazioni recenti relative all'azioni ordinarie dell'emittente. Dopo uno split azionario inverso di 30 giugno 2025 di una a cinque, Ainos KY possiede direttamente 491,263 azioni, che rappresentano 9,13% del numero di azioni post-split ampliato. La dichiarazione rende note ulteriori relazioni di voto: 933,958 azioni in virtù di un accordo di voto datato 26 gennaio 2024100,500 azioni in base a un accordo di voto datato 7 marzo 2024, 635,652 azioni legate a ASE Test tramite un accordo datato 3 maggio 2024 (inclusi convertibili e warrant), 1,037,206 azioni in base a un accordo datato 15 agosto 202455,275 azioni in base a un accordo datato 10 marzo 2025.

La dichiarazione indica che le detenzioni dirette di 491,263 azioni sono state acquisite per scopi di investimento, mentre TCNT ha venduto 62,794 azioni tra 25 giugno 2025 e 6 ottobre 2025 per scopi operativi generali. Nessun altro contratto materiale oltre agli accordi di voto divulgati è riportato.

Ainos Inc. modificó su Schedule 13D para reportar la propiedad y las transacciones recientes relacionadas con las acciones ordinarias del emisor. Después de un split inverso 1 por 5 de acciones el 30 de junio de 2025, Ainos KY posee directamente 491,263 acciones, que representan 9.13% de la base ampliada de recuento de acciones. El informe revela relaciones de voto adicionales: 933,958 acciones bajo un acuerdo de voto del 26 de enero de 2024 con el Tsai Group, 100,500 acciones bajo un acuerdo de voto del 7 de marzo de 2024, 635,652 acciones vinculadas a ASE Test mediante un acuerdo del 3 de mayo de 2024 (incluidos los notas convertibles y warrants), 1,037,206 acciones bajo un acuerdo del 15 de agosto de 2024 con TCNT, y 55,275 acciones bajo un acuerdo del 10 de marzo de 2025.

La declaración indica que las participaciones directas de 491,263 acciones se obtuvieron para propósitos de inversión, mientras que TCNT vendió 62,794 acciones entre 25 de junio de 2025 y 6 de octubre de 2025 para fines operativos generales. No se reportan otros contratos materiales además de los acuerdos de voto divulgados.

Ainos Inc. 의 Schedule 13D 를 개정하여 발행인의 보통주에 대한 소유 및 최근 거래를 보고합니다. 2025년 6월 30일의 1대5 역분할 이후, Ainos KY 가 직접 보유한 주식은 491,263 주로 확장된 주식수 기준의 9.13% 를 차지합니다. 공시는 추가적인 의결 관계를 밝힙니다: 933,958 주는 2024년 1월 26일 Tsai Group과의 의결계약, 100,500 주는 2024년 3월 7일 의결계약, 635,652 주는 2024년 5월 3일 ASE Test 와의 계약(전환사채 및 워런트 포함), 1,037,206 주는 2024년 8월 15일 TCNT 와의 계약, 55,275 주는 2025년 3월 10일 계약에 따라 입니다.

해당 491,263 주의 직접 보유분은 투자 목적 으로 취득되었으며, TCNT 는 2025년 6월 25일에서 2025년 10월 6일 사이에 62,794 주를 매도하여 일반 운용 목적을 달성했습니다. 공시된 의결계약 외의 다른 중요한 계약은 보고되지 않습니다.

Ainos Inc. a modifié son Schedule 13D pour rendre compte de la propriété et des transactions récentes concernant les actions ordinaires de l'émetteur. Après une scission inverse de 30 juin 2025 d'un pour cinq, Ainos KY détient directement 491,263 actions, ce qui représente 9,13% du nombre d'actions post-split élargi. Le dossier révèle des relations de vote supplémentaires : 933,958 actions dans le cadre d'un accord de vote daté du 26 janvier 2024 avec le Tsai Group, 100,500 actions dans le cadre d'un accord de vote daté du 7 mars 2024, 635,652 actions liées à ASE Test via un accord daté du 3 mai 2024 (y compris les notes convertibles et les warrants), 1,037,206 actions dans le cadre d'un accord daté du 15 août 2024 avec TCNT, et 55,275 actions dans le cadre d'un accord daté du 10 mars 2025.

Le dossier indique que les détentions directes de 491,263 actions ont été acquises à des fins d'investissement, tandis que TCNT a vendu 62,794 actions entre le 25 juin 2025 et le 6 octobre 2025 pour des fins d'exploitation générale. Aucun autre contrat matériel au-delà des accords de vote divulgués n'est signalé.

Ainos Inc. hat seinen Schedule 13D geändert, um Eigentum und jüngste Transaktionen im Zusammenhang mit den Stammaktien des Emittenten zu melden. Nach einem 6/30/2025 1-für-5-Reverse-Split hält Ainos KY direkt 491,263 Aktien, was 9,13% der erweiterten Aktienanzahl entspricht. Die Einreichung offenbart zusätzliche Stimmrechtsverhältnisse: 933,958 Aktien gemäß einer Abstimmungsvereinbarung vom 26.01.2024 mit der Tsai-Gruppe, 100,500 Aktien gemäß einer Abstimmungsvereinbarung vom 07.03.2024, 635,652 Aktien im Zusammenhang mit ASE Test durch eine Vereinbarung vom 03.05.2024 (einschließlich Wandelanleihen und Warrants), 1,037,206 Aktien gemäß einer Vereinbarung vom 15.08.2024 mit TCNT und 55,275 Aktien gemäß einer Vereinbarung vom 10.03.2025.

Die Einreichung gibt an, dass die direkten Halte von 491,263 Aktien zu Anlagedispositionszwecken erworben wurden, während TCNT zwischen dem 25.06.2025 und dem 06.10.2025 62,794 Aktien verkauft hat, für allgemeine Betriebsausgaben. Es werden keine weiteren materiellen Verträge außer den offengelegten Abstimmungsvereinbarungen berichtet.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
The number of securities in Row 7 includes, after giving effect to the one-for-five reverse stock split of the Issuer's common stock effected on June 30, 2025 (the "June 2025 Reverse Split"), (i) 491,263 shares of common stock, $0.01 par value, of Ainos, Inc., a Texas corporation (the "Issuer"), owned directly by Ainos Inc., a Cayman Islands company ("Ainos KY"), (ii) 933,958 shares pursuant to a Voting Agreement dated January 26, 2024 (the "2024 Voting Agreement"), by and among the Reporting Person, and Chun-Hsien Tsai, Ting Chuan Lee, Chun-Jung Tsai, and Chung-Yi Tsai (the "Tsai Group"); (iii) 100,500 shares of common stock pursuant to a Voting Agreement dated March 7, 2024 (the "2024 Voting Agreement II") with Chih-Heng Lu; (iv) 635,652 shares pursuant to a Voting Agreement dated May 3, 2024 between Ainos KY and ASE Test, Inc. ("ASE Test" and the "ASE Voting Agreement") (with the 635,652 ASE Test shares consisting of the following (a) 11,777 shares owned by ASE Test, (b) 99,875 shares issuable to ASE Test upon conversion of outstanding convertible notes of the Issuer (c) 424,000 shares issuable to ASE Test upon conversion of a convertible note of the Issuer issuable within 60 days), and (d) 100,000 shares issuable to ASE Test upon exercise of warrants to purchase 100,000 shares of the Issuer with ASE Test, (v) 1,037,206 shares pursuant to a Voting Agreement dated August 15, 2024 between Ainos KY and Taiwan Carbon Nano Technology Corporation ("TCNT Voting Agreement"), and (vi) 55,275 shares pursuant to a Voting Agreement dated March 10, 2025 between Ainos KY and Hsin-Liang Lee (the "2025 Voting Agreement"). The numbers in Rows 9, 11 and 13 represents beneficial ownership of 491,263 shares of common stock of the Issuer, consisting of 491,263 shares owned directly by Ainos KY and excludes (i) 933,958 shares pursuant to the 2024 Voting Agreement; (ii) 100,500 shares of common stock pursuant to the 2024 Voting Agreement II; (iii) 635,652 shares pursuant to the ASE Voting Agreement, (iv) 1,037,206 shares pursuant to a Voting Agreement dated August 15, 2024 between Ainos KY and Taiwan Carbon Nano Technology Corporation, and (v) 55,275 shares pursuant to the 2025 Voting Agreement. The percentage in Row 13 is based on the sum of, after giving effect to the June 2025 Reverse Split, (i) 4,759,021 shares of Common Stock outstanding as of September 5, 2025 as set forth in the prospectus supplement of the Issuer filed with the SEC on September 5, 2025, 2025 and (ii) 623,875 total shares issuable to ASE Test upon conversion of outstanding convertible note and exercisable warrant of the Issuer. This Amendment No. 12 to Schedule 13D ("Amendment No. 11") amends and supplements the Schedule 13D dated April 28, 2021 (the "Original Statement"), as amended and restated by Amendment No. 1 dated December 13, 2023, as amended by Amendment No. 2 dated March 8, 2022, Amendment No. 3 dated September 2, 2022, Amendment No. 4 dated August 15, 2023, Amendment No. 5 dated January 29, 2024, Amendment No. 6 dated March 11, 2024, Amendment No. 7 dated May 6, 2024, Amendment No.8 dated August 20, 2024, Amendment No.9 dated November 26, 2024, Amendment No.10 dated March 12, 2025, and Amendment No. 11 dated April 9, 2025 (the Original Statement, as so amended shall be known as the "Statement"), with respect to the Common Stock of the Issuer. Unless otherwise indicated, all capitalized terms used herein shall have the same meaning as set forth in the Statement. Except as set forth below, there are no changes to the information set forth in the Statement. Items 2, 3, 4, 5 and 6 of the Statement are hereby amended as follows:


SCHEDULE 13D


Ainos Inc.
Signature:/s/ Chun-Hsien Tsai
Name/Title:Chun-Hsien Tsai/Director and CEO
Date:10/09/2025

FAQ

What does Ainos KY own in Ainos, Inc. (AIMD)?

Ainos KY directly owns 491,263 shares, reported as 9.13% on a post-reverse-split basis.

How many shares are subject to voting agreements linked to the reporting person?

Voting agreements disclosed total 933,958 (Tsai Group), 100,500, 635,652 (ASE Test), 1,037,206 (TCNT-related), and 55,275 shares.

Did any sales occur recently by affiliated parties?

Yes. TCNT sold 62,794 shares between June 25, 2025 and October 6, 2025 for general operating purposes.

Were there corporate actions that affected share counts?

The issuer effected a one-for-five reverse stock split on June 30, 2025, which adjusted reported share counts.

Are there other agreements that could affect voting or dilution?

Yes. The ASE Voting Agreement includes shares issuable from convertible notes and warrants totaling portions of the 635,652 shares disclosed.
Ainos Inc

NASDAQ:AIMD

AIMD Rankings

AIMD Latest News

AIMD Latest SEC Filings

AIMD Stock Data

19.13M
1.89M
56.73%
0.13%
2.59%
Medical Devices
Pharmaceutical Preparations
Link
United States
SAN DIEGO